tiprankstipranks
Eloxx Pharmaceuticals Inc (DE:397)
FRANKFURT:397

Eloxx Pharmaceuticals (397) Stock News & Sentiment

0 Followers
Eloxx Pharmaceuticals Announces Reverse Stock Split Effective
PremiumPress Releases
Eloxx Pharmaceuticals Announces Reverse Stock Split Effective
1y ago
Eloxx Pharmaceuticals announces 1-for-40 reverse stock split
PremiumThe Fly
Eloxx Pharmaceuticals announces 1-for-40 reverse stock split
1y ago
Eloxx Pharmaceuticals Reports Third Quarter 2022 Financial and Operating Results and Provides Business Update
PremiumPress Releases
Eloxx Pharmaceuticals Reports Third Quarter 2022 Financial and Operating Results and Provides Business Update
1y ago

News Score - Last 7 Days

Neutral
DE:397
Sector Average
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average61%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:397’s Media Buzz Sentiment?
2 articles about DE:397 were published this week. In an average week, 1 articles are published.
    What is DE:397’s weekly average amount of articles?
    In an average week, 1 articles about DE:397 are published.
      What is DE:397’s News Sentiment?
      50% of articles about DE:397 were positive this week, compared to its sector average of 61%.
        Healthcare Stocks that are Trending in the News
        RIGLRigel
        DNLIDenali Therapeutics
        NKTXNkarta
        AVXLAnavex Life Sciences
        RPTXRepare Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis